| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BRIEF COMMUNICATIONS |





*Department of Pathology and Medical Biology and
Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands; and
Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands
Correspondence: Eelke M. Bos, Department of Pathology and Medical Biology, University Medical Center Groningen, PO Box 30.001, Hanzeplein 1, 9700RB Groningen, The Netherlands. Phone: +31-50-3614179; Fax: +31-50-3632796; E-mail: e.m.bos{at}path.umcg.nl
Received for publication December 16, 2008. Accepted for publication May 20, 2009.
Hydrogen sulfide (H2S) can induce a hypometabolic, hibernation-like state in mammals when given in subtoxic concentrations. Pharmacologically reducing the demand for oxygen is a promising strategy to minimize unavoidable hypoxia-induced injury such as ischemia/reperfusion injury during renal transplantation. Here we show that H2S reduces metabolism in vivo, ex vivo, and in vitro. Furthermore, we demonstrate the beneficial effects of H2S-induced hypometabolism in a model of bilateral renal ischemia/reperfusion injury using three different treatment strategies. The results demonstrate striking protective effects on survival, renal function, apoptosis, and inflammation. A hypometabolic state induced by H2S might have therapeutic potential to protect kidneys that suffer from hypoxia.
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673